AMBASSADOR and PemCab: Trials of Note for Advanced Bladder Cancer

Guru Sonpavde, MD, Advent Health, provides a detailed overview of 2 of the bladder cancer trials of note at the American Society of Clinical Oncology Genitourinary Cancers Symposium.

AMBASSADOR investigates adjuvant pembrolizumab in patients with muscle-invasive and locally advanced bladder cancer.

PemCab assesses cabozantinib plus pembrolizumab as first-line therapy for cisplatin-ineligible advanced urothelial carcinoma.